SCHEMBL21332979

SCHEMBL21332979

Cc1c(C(=O)Cn2cc(Br)ncc2=O)cnn1Cc1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.43
S1PR2 O95136 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.41
KMT2A Q03164 1/20 0.41
PFKFB3 Q16875 1/20 0.40
ALDH1A1 P00352 1/20 0.40
TSHR P16473 2/20 0.38
TP53 P04637 2/20 0.38
NPC1 O15118 1/20 0.38
LMNA P02545 1/20 0.38
MAPT P10636 1/20 0.38
RAB9A P51151 1/20 0.38
PTGDR2 Q9Y5Y4 3/20 0.38
MCHR1 Q99705 4/20 0.37
POLB P06746 1/20 0.37
GAA P10253 1/20 0.37
HPGD P15428 1/20 0.36
MAPK1 P28482 1/20 0.36
L3MBTL1 Q9Y468 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21332946 0.86 S1PR2 (0.47) KDM4ES1PR2SMN1; SMN2KMT2APFKFB3
SCHEMBL21333188 0.84 S1PR2 (0.43) KDM4ES1PR2SMN1; SMN2KMT2APFKFB3
SCHEMBL21333532 0.84 KDM4E (0.44) KDM4ES1PR2SMN1; SMN2KMT2APFKFB3
SCHEMBL21332883 0.82 S1PR2 (0.44) KDM4ES1PR2SMN1; SMN2KMT2APFKFB3
SCHEMBL21332978 0.82 S1PR2 (0.47) KDM4ES1PR2SMN1; SMN2KMT2AALDH1A1
SCHEMBL21333333 0.81 KMT2A (0.43) KDM4ES1PR2SMN1; SMN2KMT2APFKFB3
SCHEMBL21333070 0.81 S1PR2 (0.46) KDM4ES1PR2SMN1; SMN2KMT2APFKFB3
SCHEMBL21333140 0.81 PTGDR2 (0.45) KDM4ESMN1; SMN2KMT2APFKFB3ALDH1A1
SCHEMBL21333325 0.80 SMN1; SMN2 (0.45) KDM4ES1PR2SMN1; SMN2KMT2APFKFB3
SCHEMBL21332788 0.80 KDM4E (0.47) KDM4ESMN1; SMN2KMT2APFKFB3ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3762377-B1 PYRIDINONE- AND PYRIDAZINONE-BASED COMPOUNDS AND MEDICAL USES THEREOF UNIV CORNELL (US) 2025-08-20 EP disclosed
US-11964960-B2 Pyridinone- and pyridazinone-based compounds and uses thereof CORNELL UNIVERSITY (US) 2024-04-23 US disclosed
EP-3762377-A1 PYRIDINONE- AND PYRIDAZINONE-BASED COMPOUNDS AND MEDICAL USES THEREOF Cook, Timothy, H. (US) 2021-01-13 EP disclosed
US-20200407339-A1 PYRIDINONE- AND PYRIDAZINONE-BASED COMPOUNDS AND USES THEREOF TRI-INSTITUTIONAL THERAPEUTICS DISCOVERY INSTITUTE 2020-12-31 US disclosed
US-20200407339-A1 PYRIDINONE- AND PYRIDAZINONE-BASED COMPOUNDS AND USES THEREOF TRI-INSTITUTIONAL THERAPEUTICS DISCOVERY INSTITUTE 2020-12-31 US disclosed
WO-2019173790-A1 PYRIDINONE- AND PYRIDAZINONE-BASED COMPOUNDS AND MEDICAL USES THEREOF HLA TIMOTHY (US) 2019-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200407339-A1 PYRIDINONE- AND PYRIDAZINONE-BASED COMPOUNDS AND USES THEREOF PTGER1, LOXL1, COL1A1 KDM4E 2671/4885S1PR2 601/4885SMN1; SMN2 3979/4885
US-11964960-B2 Pyridinone- and pyridazinone-based compounds and uses thereof PTGER1, LOXL1, COL1A1 KDM4E 2671/4885S1PR2 601/4885SMN1; SMN2 3979/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.